NANOBODY Trademark

Trademark Overview


On Wednesday, January 12, 2005, a trademark application was filed for NANOBODY with the United States Patent and Trademark Office. The USPTO has given the NANOBODY trademark a serial number of 79015208. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, January 13, 2015. This trademark is owned by ABLYNX N.V.. The NANOBODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, infectious diseases; veterinary preparations and substances for treating livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, diseases of the central nervous system, infectious diseases; diagnostic and therapeutic preparations for medical and veterinary use; biological cultures for clinical medical and veterinary use; insecticides

Services rendered by laboratory technicians, chemists, engineers, biotechnologists, namely, scientific research and laboratory research services in the field of bacteriology and biotechnology purposes; biotechnical research; consultancy in the field of biotechnology; industrial property consultancy; research with respect to the issues of industrial property protection in relation to the biotechnical field
nanobody

General Information


Serial Number79015208
Word MarkNANOBODY
Filing DateWednesday, January 12, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, January 13, 2015
Registration Number3114496
Registration DateTuesday, July 11, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, infectious diseases; veterinary preparations and substances for treating livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, diseases of the central nervous system, infectious diseases; diagnostic and therapeutic preparations for medical and veterinary use; biological cultures for clinical medical and veterinary use; insecticides
Goods and ServicesServices rendered by laboratory technicians, chemists, engineers, biotechnologists, namely, scientific research and laboratory research services in the field of bacteriology and biotechnology purposes; biotechnical research; consultancy in the field of biotechnology; industrial property consultancy; research with respect to the issues of industrial property protection in relation to the biotechnical field

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABLYNX N.V.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressBE

Party NameABLYNX N.V.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressB-9052 Zwijnaarde
BE

Party NameABLYNX N.V.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressB-9052 Zwijnaarde
BE

Trademark Events


Event DateEvent Description
Friday, July 31, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, July 31, 2015DEATH OF INTERNATIONAL REGISTRATION
Monday, October 27, 2014GENERIC MADRID TRANSACTION SENT TO IB
Monday, October 27, 2014GENERIC MADRID TRANSACTION CREATED
Thursday, June 5, 2014NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 27, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 27, 2013CANCELLED SECTION 71
Friday, December 10, 2010CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 5, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 16, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 16, 2007FINAL DISPOSITION PROCESSED
Tuesday, March 13, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 11, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, April 18, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2006NOTICE OF PUBLICATION
Monday, February 27, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 24, 2006ASSIGNED TO LIE
Friday, February 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 9, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, January 30, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 2006PAPER RECEIVED
Friday, October 28, 2005REFUSAL PROCESSED BY IB
Tuesday, October 11, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, October 9, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, October 8, 2005NON-FINAL ACTION WRITTEN
Friday, October 7, 2005ASSIGNED TO EXAMINER
Friday, October 7, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, October 6, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB